• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
POH
Click for more information
0.00% 0.0¢

PROGRESS 2023-2 TRUST - Announcements

Market Cap $0  ! watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
POH Notification of AGM Date27/03/19
POH Appendix 4G and Corporate Governance Statement27/03/19
POH Annual Report - 31 December 201827/03/19
POH Changes to Leadership TeamPRICE SENSITIVE27/03/19
POH Appendix 4E - Preliminary Final ReportPRICE SENSITIVE28/02/19
POH Updated Presentation to Support CEO Partnering Meetings07/02/19
POH FDA meeting provides guidance for TPM/Oxymorphone patchPRICE SENSITIVE17/01/19
POH Resignation and Appointment of Company Secretary and CFO24/12/18
POH Reinstatement to Offical QuotationPRICE SENSITIVE19/12/18
POH Phosphagenics and Mylan Agree SettlementPRICE SENSITIVE19/12/18
POH Settlement Negotiations13/12/18
POH Suspension from Official QuotationPRICE SENSITIVE12/12/18
POH Trading HaltPRICE SENSITIVE10/12/18
POH Voluntary Withdrawal from OTCQX03/12/18
POH Receipt of R&D Tax Incentive27/11/18
POH Change in substantial holding23/11/18
POH Phosphagenics Arbitration Award IssuedPRICE SENSITIVE12/11/18
POH Receipt of R&D Tax IncentivePRICE SENSITIVE08/11/18
POH Response to ASX Price QueryPRICE SENSITIVE26/10/18
POH Phosphagenics Receives Further Arbitration Process UpdatePRICE SENSITIVE23/10/18
POH Phosphagenics Licensing Agreement UpdatePRICE SENSITIVE10/09/18
POH Phosphagenics Receives Arbitration Update from SIAC04/09/18
POH Updated Non-Confidential Presentation CEO USA Roadshow13/08/18
POH Phosphagenics Newsletter - August 201813/08/18
POH Half Year AccountsPRICE SENSITIVE13/08/18
POH Phosphagenics Still Awaits SIAC Arbitration Update08/06/18 download Created with Sketch. 222.3KB
POH Final Director's Interest Notice31/05/18 download Created with Sketch. 213.45KB
POH Retirement of Non-Executive Director25/05/18 download Created with Sketch. 213.84KB
POH 2018 Annual General Meeting Results25/05/18 download Created with Sketch. 349.47KB
POH AGM Chairman's Address and CEO PresentationPRICE SENSITIVE25/05/18 download Created with Sketch. 720.65KB
POH Phospahgenics CEO Roadshow Presentation14/05/18
POH Notice of General Meeting/Proxy Form24/04/18
POH Phosphagenics Investor Presentations16/04/18
POH Phosphagenics Notification of AGM Date28/03/18
POH Appendix 4G Corporate Governance Statement28/03/18
POH Annual Report to shareholders28/03/18
POH Phosphagenics CEO Update Teleconference20/03/18
POH Phosphagenics Newsletter - March 201820/03/18
POH Terumo Shifts Focus From Oxymorphone Patch to InjectablesPRICE SENSITIVE20/03/18
POH Preliminary Final ReportPRICE SENSITIVE28/02/18
POH Phosphagenics Placement Secures A$1.37 millionPRICE SENSITIVE18/01/18
POH Appendix 3B18/01/18
POH Phosphagenics Placement Cleansing Notice18/01/18
POH Phosphagenics Receipt of R&D Tax IncentivePRICE SENSITIVE17/01/18
POH Ceasing to be a substantial holder05/01/18
POH Phosphagenics Announces Results of Dairy TrialPRICE SENSITIVE22/12/17
POH TPM Improves Negative Effects of Heat Stress in PoultryPRICE SENSITIVE15/12/17
POH Phosphagenics Multinational License for TPM in Personal CarePRICE SENSITIVE04/12/17
POH Phosphagenics Update on TPM/Propofol Development ProgramPRICE SENSITIVE09/11/17
POH Phosphagenics Mylan Arbitration Hearing Concluded06/11/17
POH Change in substantial holding01/11/17
POH Becoming a substantial holder01/11/17
POH Lodgement of Appendix 3Y31/10/17
POH Appendix 3B30/10/17
POH Phosphagenics Entitlement Offer Raises Over AUD3M25/10/17
POH Phosphagenics Extension of Closing Date of Entitlement Offer09/10/17
POH CEO Quarterly Update Teleconference04/10/17
POH Phosphagenics Newsletter - October 201704/10/17
POH Despatch of Entitlement Offer Forms and Information Booklet03/10/17
POH Phosphagenics Entitlement Offer Information BookletPRICE SENSITIVE03/10/17
POH Phosphagenics Entitlement Offer - Ineligible Shareholders28/09/17
POH Phosphagenics Entitlement Offer - Eligible Shareholders28/09/17
POH Phosphagenics Rights Issue Cleansing Notice26/09/17
POH Phosphagenics Rights Issue - Appendix 3B26/09/17
POH Phosphagenics Investor Presentation for Rights Issue26/09/17
POH Phosphagenics Announces Equity RaisingPRICE SENSITIVE26/09/17
POH Phosphagenics Signs Term Sheet TPM Diclofenac Gel in AsiaPRICE SENSITIVE26/09/17
POH Trading HaltPRICE SENSITIVE22/09/17
POH Phosphagenics Investor Presentation01/09/17
POH Phosphagenics Market Update - Potential Return of CapitalPRICE SENSITIVE01/09/17
POH Phosphagenics Half Year Financial Results31/08/17
POH June 2017 Half-year Financial Report and Appendix 4DPRICE SENSITIVE31/08/17
POH Phosphagenics Signs Patch Development Agreement with TerumoPRICE SENSITIVE22/08/17
POH Phosphagenics Sells BioElixia Brand to Pure Beauty AustraliaPRICE SENSITIVE10/08/17
POH Appendix 3B05/06/17
POH 2017 AGM Results31/05/17
POH 2017 AGM Chairman and CEO Presentations31/05/17
POH Retirement of Non-Executive Director30/05/17
POH POH Mylan Arbitration Update- Expert Report on Damages FiledPRICE SENSITIVE29/05/17
POH Phosphagenics - May 2017 Newsletter26/05/17
POH Appendix 4G Corporate Governance Statement28/04/17
POH Annual Report to shareholders28/04/17
POH Notice of Annual General Meeting/Proxy Form28/04/17
POH Phosphagenics Announces Transition of Chairman of the Board21/04/17
POH Phosphagenics and IAH Cease All PartnershipsPRICE SENSITIVE09/03/17
POH Change of Director's Interest Notice03/03/17
POH CEO Quarterly Update Teleconference01/03/17
POH Phosphagenics - March 2017 Newsletter01/03/17
POH Receipt of R&D Tax IncentivePRICE SENSITIVE01/03/17
POH Phosphagenics Full Year Financial Results28/02/17
POH Appendix 4E and Annual Financial ReportPRICE SENSITIVE28/02/17
POH Phosphagenics Non-Binding Term Sheet for OxyM Patch in JapanPRICE SENSITIVE31/01/17
POH Change of Registered Office and Principal Place of Business20/01/17
POH Phosphagenics December Newsletter19/12/16
POH Phosphagenics Poultry Feed Study Reports Positive DataPRICE SENSITIVE15/12/16
POH Reformulation TPM/Oxymorphone CompletePRICE SENSITIVE12/12/16
POH Phosphagenics ProPhase Arbitration Ruling Handed DownPRICE SENSITIVE16/11/16
POH Phosphagenics Extends Diligence Term for Patches in Japan10/11/16
POH Phosphagenics Investor Presentations-POH.AX 12/10/16
POH Appendix 3B-POH.AX 06/10/16
POH Notification of AGM Date
27/03/19
POH Appendix 4G and Corporate Governance Statement
27/03/19
POH Annual Report - 31 December 2018
27/03/19
POH Changes to Leadership Team
27/03/19PRICE SENSITIVE
POH Appendix 4E - Preliminary Final Report
28/02/19PRICE SENSITIVE
POH Updated Presentation to Support CEO Partnering Meetings
07/02/19
POH FDA meeting provides guidance for TPM/Oxymorphone patch
17/01/19PRICE SENSITIVE
POH Resignation and Appointment of Company Secretary and CFO
24/12/18
POH Reinstatement to Offical Quotation
19/12/18PRICE SENSITIVE
POH Phosphagenics and Mylan Agree Settlement
19/12/18PRICE SENSITIVE
POH Settlement Negotiations
13/12/18
POH Suspension from Official Quotation
12/12/18PRICE SENSITIVE
POH Trading Halt
10/12/18PRICE SENSITIVE
POH Voluntary Withdrawal from OTCQX
03/12/18
POH Receipt of R&D Tax Incentive
27/11/18
POH Change in substantial holding
23/11/18
POH Phosphagenics Arbitration Award Issued
12/11/18PRICE SENSITIVE
POH Receipt of R&D Tax Incentive
08/11/18PRICE SENSITIVE
POH Response to ASX Price Query
26/10/18PRICE SENSITIVE
POH Phosphagenics Receives Further Arbitration Process Update
23/10/18PRICE SENSITIVE
POH Phosphagenics Licensing Agreement Update
10/09/18PRICE SENSITIVE
POH Phosphagenics Receives Arbitration Update from SIAC
04/09/18
POH Updated Non-Confidential Presentation CEO USA Roadshow
13/08/18
POH Phosphagenics Newsletter - August 2018
13/08/18
POH Half Year Accounts
13/08/18PRICE SENSITIVE
POH Phosphagenics Still Awaits SIAC Arbitration Update
08/06/18 download Created with Sketch. 222.3KB
POH Final Director's Interest Notice
31/05/18 download Created with Sketch. 213.45KB
POH Retirement of Non-Executive Director
25/05/18 download Created with Sketch. 213.84KB
POH 2018 Annual General Meeting Results
25/05/18 download Created with Sketch. 349.47KB
POH AGM Chairman's Address and CEO Presentation
25/05/18PRICE SENSITIVE download Created with Sketch. 720.65KB
POH Phospahgenics CEO Roadshow Presentation
14/05/18
POH Notice of General Meeting/Proxy Form
24/04/18
POH Phosphagenics Investor Presentations
16/04/18
POH Phosphagenics Notification of AGM Date
28/03/18
POH Appendix 4G Corporate Governance Statement
28/03/18
POH Annual Report to shareholders
28/03/18
POH Phosphagenics CEO Update Teleconference
20/03/18
POH Phosphagenics Newsletter - March 2018
20/03/18
POH Terumo Shifts Focus From Oxymorphone Patch to Injectables
20/03/18PRICE SENSITIVE
POH Preliminary Final Report
28/02/18PRICE SENSITIVE
POH Phosphagenics Placement Secures A$1.37 million
18/01/18PRICE SENSITIVE
POH Appendix 3B
18/01/18
POH Phosphagenics Placement Cleansing Notice
18/01/18
POH Phosphagenics Receipt of R&D Tax Incentive
17/01/18PRICE SENSITIVE
POH Ceasing to be a substantial holder
05/01/18
POH Phosphagenics Announces Results of Dairy Trial
22/12/17PRICE SENSITIVE
POH TPM Improves Negative Effects of Heat Stress in Poultry
15/12/17PRICE SENSITIVE
POH Phosphagenics Multinational License for TPM in Personal Care
04/12/17PRICE SENSITIVE
POH Phosphagenics Update on TPM/Propofol Development Program
09/11/17PRICE SENSITIVE
POH Phosphagenics Mylan Arbitration Hearing Concluded
06/11/17
POH Change in substantial holding
01/11/17
POH Becoming a substantial holder
01/11/17
POH Lodgement of Appendix 3Y
31/10/17
POH Appendix 3B
30/10/17
POH Phosphagenics Entitlement Offer Raises Over AUD3M
25/10/17
POH Phosphagenics Extension of Closing Date of Entitlement Offer
09/10/17
POH CEO Quarterly Update Teleconference
04/10/17
POH Phosphagenics Newsletter - October 2017
04/10/17
POH Despatch of Entitlement Offer Forms and Information Booklet
03/10/17
POH Phosphagenics Entitlement Offer Information Booklet
03/10/17PRICE SENSITIVE
POH Phosphagenics Entitlement Offer - Ineligible Shareholders
28/09/17
POH Phosphagenics Entitlement Offer - Eligible Shareholders
28/09/17
POH Phosphagenics Rights Issue Cleansing Notice
26/09/17
POH Phosphagenics Rights Issue - Appendix 3B
26/09/17
POH Phosphagenics Investor Presentation for Rights Issue
26/09/17
POH Phosphagenics Announces Equity Raising
26/09/17PRICE SENSITIVE
POH Phosphagenics Signs Term Sheet TPM Diclofenac Gel in Asia
26/09/17PRICE SENSITIVE
POH Trading Halt
22/09/17PRICE SENSITIVE
POH Phosphagenics Investor Presentation
01/09/17
POH Phosphagenics Market Update - Potential Return of Capital
01/09/17PRICE SENSITIVE
POH Phosphagenics Half Year Financial Results
31/08/17
POH June 2017 Half-year Financial Report and Appendix 4D
31/08/17PRICE SENSITIVE
POH Phosphagenics Signs Patch Development Agreement with Terumo
22/08/17PRICE SENSITIVE
POH Phosphagenics Sells BioElixia Brand to Pure Beauty Australia
10/08/17PRICE SENSITIVE
POH Appendix 3B
05/06/17
POH 2017 AGM Results
31/05/17
POH 2017 AGM Chairman and CEO Presentations
31/05/17
POH Retirement of Non-Executive Director
30/05/17
POH POH Mylan Arbitration Update- Expert Report on Damages Filed
29/05/17PRICE SENSITIVE
POH Phosphagenics - May 2017 Newsletter
26/05/17
POH Appendix 4G Corporate Governance Statement
28/04/17
POH Annual Report to shareholders
28/04/17
POH Notice of Annual General Meeting/Proxy Form
28/04/17
POH Phosphagenics Announces Transition of Chairman of the Board
21/04/17
POH Phosphagenics and IAH Cease All Partnerships
09/03/17PRICE SENSITIVE
POH Change of Director's Interest Notice
03/03/17
POH CEO Quarterly Update Teleconference
01/03/17
POH Phosphagenics - March 2017 Newsletter
01/03/17
POH Receipt of R&D Tax Incentive
01/03/17PRICE SENSITIVE
POH Phosphagenics Full Year Financial Results
28/02/17
POH Appendix 4E and Annual Financial Report
28/02/17PRICE SENSITIVE
POH Phosphagenics Non-Binding Term Sheet for OxyM Patch in Japan
31/01/17PRICE SENSITIVE
POH Change of Registered Office and Principal Place of Business
20/01/17
POH Phosphagenics December Newsletter
19/12/16
POH Phosphagenics Poultry Feed Study Reports Positive Data
15/12/16PRICE SENSITIVE
POH Reformulation TPM/Oxymorphone Complete
12/12/16PRICE SENSITIVE
POH Phosphagenics ProPhase Arbitration Ruling Handed Down
16/11/16PRICE SENSITIVE
POH Phosphagenics Extends Diligence Term for Patches in Japan
10/11/16
POH Phosphagenics Investor Presentations-POH.AX
12/10/16
POH Appendix 3B-POH.AX
06/10/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.0¢ 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
POH (ASX) Chart

Top Stories

Sales growth pushes Lovisa's fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due to organised crime links.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.